RBM8A and breast carcinoma: To investigate whether HSPD1/RBM8A/G3BP1 were involved in breast cancer progression clinically, the BCIP database (http://www.omicsnet.org/bcancer/) was used to analyze the relationship between HSPD1/RBM8A/G3BP1 expression and clinicopathological characteristics of breast cancer patients.